苓桂术甘汤通过抑制巨噬细胞STING介导炎症改善高脂饮食诱导的小鼠肝脏脂质沉积
本研究探讨苓桂术甘汤(LGZG)对高脂饮食(HFD)诱导的非酒精性脂肪性肝病(NAFLD)小鼠模型的作用及机制。研究采用H&E染色、免疫荧光、免疫组化、油红染色、实时PCR、Western blot和ELISA等方法,结合骨髓来源巨噬细胞和原代肝巨噬细胞体外实验。结果显示LGZG显著改善HFD诱导的肝脂肪变性、氧化应激、肝线粒体损伤和线粒体DNA释放,其机制与抑制肝巨噬细胞中STING-TBK1-NF-κB通路有关。
要点
- 苓桂术甘汤可改善HFD诱导的小鼠肝脂肪变性、氧化应激和线粒体损伤。
- 苓桂术甘汤的关键成分直接抑制肝巨噬细胞中STING-TBK1-NF-κB通路激活。
- 抑制STING介导的炎症减少IFNβ和TNFα释放,减轻肝细胞脂质沉积。
核心结论
- 苓桂术甘汤通过抑制肝巨噬细胞中STING-TBK1-NF-κB通路改善HFD诱导的肝脏脂质沉积。
研究设计与样本
- 采用HFD诱导NAFLD小鼠模型,通过H&E染色、免疫荧光和免疫组化检测LGZG体内抗炎和抗脂肪变性作用。
- 体外使用小鼠骨髓来源巨噬细胞(BMDMs)和原代肝巨噬细胞,分别用STING特异性激动剂(DMXAA)、LGZG及其关键成分处理。
- 将处理后的巨噬细胞培养上清与棕榈酸处理的鼠原代肝细胞或鼠肝细胞系AML-12共培养,检测STING通路激活是否参与LGZG抗脂肪变性作用。
- 通过油红染色检测体内外肝细胞脂质沉积,实时PCR检测小鼠肝提取物线粒体DNA释放,Western blot和ELISA检测STING-TBK1-NF-κB通路相关蛋白和炎性细胞因子表达。
主要发现
- LGZG显著改善HFD诱导的肝脂肪变性、氧化应激、肝线粒体损伤和线粒体DNA释放。
- 上述改善与HFD喂养小鼠肝脏中STING表达水平降低及STING阳性巨噬细胞浸润减少相关。
- LGZG关键成分直接抑制DMXAA、LPS诱导的肝巨噬细胞中STING-TBK1-NF-κB通路激活,减少IFNβ和TNFα释放。
- LGZG处理的肝巨噬细胞培养上清与PA刺激的肝细胞共孵育,显著抑制PA诱导的脂质沉积。
临床怎么用
- 苓桂术甘汤可能通过抑制肝巨噬细胞STING-TBK1-NF-κB通路减轻HFD相关肝脂肪变性,为NAFLD治疗提供潜在靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Stimulator of IFN genes (STING) is highly expressed in the livers of non-alcoholic fatty liver disease (NAFLD) patients and high fat diet (HFD) induced NAFLD mice model. The STING signaling-mediated inflammation has been shown to play a critical role in metabolic disorders. Lingguizhugan decoction (LGZG), a Traditional Chinese herbal decoction, has been applied to treat metabolic disorders for many years. However, whether LGZG can alleviate the progression of NAFLD through inhibiting inflammation remains unclear. This study was to determine the role of STING-mediated inflammation in the HFD-induced hepatic-lipid deposition treated with LGZG. METHODS: The anti-inflammatory and anti-steatotic effects of LGZG in vivo were detected by H&E staining, immunofluorescence and immuno-chemistry. Mice bone-marrow-derived macrophages (BMDMs) and primary liver macrophages were treated with STING-specific agonist (DMXAA), LGZG and its critical components respectively. The treated culture supernatant of BMDMs and primary liver macrophages from each group was co-cultured with palmitic acid-treated mouse primary hepatocytes or mouse liver cell line AML-12 respectively to detect whether the activation of STING-mediated pathway is involved in the anti-steatotic effect of LGZG. The hepatocyte lipid deposition in vivo and in vitro were detected by oil red staining. Mitochondrial DNA release of mouse liver extracts were detected by real time PCR. The expression of proteins and inflammatory cytokines related to STING-TBK1-NF-κB pathway was detected by western blotting and ELISA. RESULTS: LGZG significantly ameliorated HFD induced hepatic steatosis, oxidative stress, hepatic mitochondrial damage and mitochondrial DNA release, which was correlated with reduction of the expression level of STING as well as the infiltration of STING-positive macrophages in the livers of HFD fed mice. The critical components of LGZG directly inhibited the activation of STING-TBK1-NF-κB pathway in liver macrophages induced by DMXAA, LPS, thereby reducing the release of IFNβ and TNFα. Co-incubating the culture supernatant of LGZG treated liver macrophages and PA-stimulated hepatocytes significantly inhibited the PA-induced lipid deposition. CONCLUSION: This study demonstrates that LGZG can ameliorate HFD-induced hepatic-lipid deposition through inhibiting STING-TBK1-NF-κB pathway in liver macrophages, which provides novel insight for elucidating the molecular mechanism of LGZG alleviating HFD induced hepatic steatosis.
引用
- Cao L, Xu E, Zheng R, et al. Traditional Chinese medicine Lingguizhugan decoction ameliorate HFD-induced hepatic-lipid deposition in mice by inhibiting STING-mediated inflammation in macrophages. Chin Med. 2022. PMID: 34983596. doi:10.1186/s13020-021-00559-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。